Aligos Therapeutics (ALGS) Cash & Equivalents (2019 - 2026)
Aligos Therapeutics (ALGS) recorded Cash & Equivalents of $30.4 million in Q2 2026, up 62.9% from $18.66 million a year earlier and up 1.4% from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Aligos Therapeutics reported Cash & Equivalents of $18.3 million, down 50.5% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -39.2% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $37 million in FY2024 (-72.7%), $135.7 million in FY2023 (+66.8%), $81.35 million in FY2022 (-56.5%) and $186.82 million in FY2021 (-15.2%).
- Quarterly Cash & Equivalents has ranged from $18.3 million in Q4 2025 to $239.73 million in Q3 2021 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in three of the last eight quarters, with an average decline of 0.5%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 653.5% in Q3 2021, against a decline of 72.7% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $29.98 million (Q1 2026), $18.3 million (Q4 2025) and $41.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Aligos Therapeutics | 49.86 Mn | -278.55 Mn | - | 30.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.40 Mn |
| Mar 31, 2026 | 29.98 Mn |
| Dec 31, 2025 | 18.30 Mn |
| Sep 30, 2025 | 41.95 Mn |
| Jun 30, 2025 | 18.66 Mn |
| Mar 31, 2025 | 73.76 Mn |
| Dec 31, 2024 | 37.00 Mn |
| Sep 30, 2024 | 35.33 Mn |
| Jun 30, 2024 | 45.08 Mn |
| Mar 31, 2024 | 24.15 Mn |
| Dec 31, 2023 | 135.70 Mn |
| Sep 30, 2023 | 70.43 Mn |
| Jun 30, 2023 | 90.83 Mn |
| Mar 31, 2023 | 78.67 Mn |
| Dec 31, 2022 | 81.35 Mn |
| Sep 30, 2022 | 86.44 Mn |
| Jun 30, 2022 | 71.17 Mn |
| Mar 31, 2022 | 104.56 Mn |
| Dec 31, 2021 | 186.82 Mn |
| Sep 30, 2021 | 239.73 Mn |
API Access
Aligos Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();